Wu et al. reviewed 428 surgically resected lung adenocarcinoma cases [23], where the PD-L1 status was determined by SP142 assay, with the results suggesting that PD-L1 expression was associated with wild type EGFR, positive ALK fusion, and KRAS mutation. This evidence concerns the gene KRAS and lung adenocarcinoma.